Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

By | July 6, 2021
Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.